任何TEAE |
86(98.9%) |
726(43.22) |
78例(96.3%) |
615(32.49) |
呼吸,胸腔和纵隔障碍 |
79(90.8%) |
309(18.40) |
64(79.0%) |
101 (14.93) |
慢性阻塞性肺疾病 |
43 (49.4%) |
96 (5.73) |
38(46.9%) |
84 (4.45) |
呼吸困难 |
40(46.0%) |
77 (4.60) |
39(48.1%) |
74 (3.91) |
咳嗽 |
17 (19.5%) |
24(1.42) |
16 (19.8%) |
20(1.06) |
Productive cough |
14(16.1%) |
21(1.24) |
8(9.9%) |
13(0.69) |
Nasopharyngitis |
12 (13.8%) |
17(1.02) |
12 (14.8%) |
14(0.73) |
Oropharyngeal pain |
10 (11.5%) |
13 (0.77) |
5(6.2%) |
7(0.37) |
Sputum discoloured |
9(10.3%) |
11(0.66) |
2 (2.5%) |
2 (0.11) |
感染和感染 |
65(74.7%) |
180 (10.73) |
54(66.7%) |
154 (8.14) |
Lower respiratory tract infection |
18 (20.7%) |
48(2.85) |
14(17.3%) |
33 (1.75) |
Upper respiratory tract infection |
8(9.2%) |
12 (0.73) |
9(11.1%) |
13(0.69) |
胃肠道功能紊乱 |
32(36.8%) |
53(3.14) |
26 (32.1%) |
47(2.48) |
Nausea |
10 (11.5%) |
14 (0.84) |
5(6.2%) |
6 (0.33) |
Diarrhoea |
8(9.2%) |
10 (0.58) |
10 (12.3%) |
12 (0.62) |
一般疾病和管理现场条件 |
23(26.4%) |
53(3.14) |
26 (32.1%) |
47(2.48) |
乏力 |
9(10.3%) |
16 (0.95) |
9(11.1%) |
10 (0.51) |
肌肉骨骼和结缔组织疾病 |
21(24.1%) |
29(1.72) |
23(28.4%) |
33 (1.75) |
皮肤和皮下组织疾病 |
17 (19.5%) |
22日(1.31) |
11(13.6%) |
11(0.58) |
神经系统紊乱 |
15(17.2%) |
22日(1.31) |
12 (14.8%) |
17 (0.91) |
头痛 |
9(10.3%) |
12 (0.73) |
10 (12.3%) |
13(0.69) |